title: Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
abstract: Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections characterize the major pathogens to which patients with cancer are susceptible, with a focus on the prevention, diagnosis, and treatment of major common and opportunistic infections. This portion of the guidelines highlights the sections on antifungal and antiviral prophylaxis. Antifungal and antiviral prophylaxis recommendations have expanded over the past few years. New agents for the treatment of fungal infections and incorporation of therapeutic drug monitoring are presented. Antiviral prophylaxis for hepatitis B and management considerations for hepatitis C and HIV have been further developed.
authors.forename: Lindsey Robert
authors.initials: LR
authors.lastname: Baden
authors.forename: Sankar
authors.initials: S
authors.lastname: Swaminathan
authors.forename: Michael
authors.initials: M
authors.lastname: Angarone
authors.forename: Gayle
authors.initials: G
authors.lastname: Blouin
authors.forename: Bernard C
authors.initials: BC
authors.lastname: Camins
authors.forename: Corey
authors.initials: C
authors.lastname: Casper
authors.forename: Brenda
authors.initials: B
authors.lastname: Cooper
authors.forename: Erik R
authors.initials: ER
authors.lastname: Dubberke
authors.forename: Ashley Morris
authors.initials: AM
authors.lastname: Engemann
authors.forename: Alison G
authors.initials: AG
authors.lastname: Freifeld
authors.forename: John N
authors.initials: JN
authors.lastname: Greene
authors.forename: James I
authors.initials: JI
authors.lastname: Ito
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Kaul
authors.forename: Mark E
authors.initials: ME
authors.lastname: Lustberg
authors.forename: Jose G
authors.initials: JG
authors.lastname: Montoya
authors.forename: Ken
authors.initials: K
authors.lastname: Rolston
authors.forename: Gowri
authors.initials: G
authors.lastname: Satyanarayana
authors.forename: Brahm
authors.initials: B
authors.lastname: Segal
authors.forename: Susan K
authors.initials: SK
authors.lastname: Seo
authors.forename: Shmuel
authors.initials: S
authors.lastname: Shoham
authors.forename: Randy
authors.initials: R
authors.lastname: Taplitz
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Topal
authors.forename: John W
authors.initials: JW
authors.lastname: Wilson
authors.forename: Karin G
authors.initials: KG
authors.lastname: Hoffmann
authors.forename: Courtney
authors.initials: C
authors.lastname: Smith
mesh_terms: D003141:Communicable Diseases / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*